Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Annals of Clinical Biochemistry|May 1, 1986
Evaluation of an immunoradiometric assay for the detection of an ovarian tumour marker, CA125, in serumM D Shelley, R G Fish
Melanoma Research|January 16, 1998
Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell linesL Blackstaffe, M D Shelley, R G Fish
The Cochrane Database of Systematic Reviews|November 1, 2001
Surgery versus radiotherapy for muscle invasive bladder cancerM D Shelley, J Barber, M D Mason
Cancer Treatment Reviews|November 19, 2002
Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic reviewM D Shelley, K Burgon, M D Mason
Antimicrobial Agents and Chemotherapy|February 1, 1985
Biliary excretion of platinum in a patient treated with cis-dichlorodiammineplatinum (II)M D Shelley, R G Fish, M Adams
European Journal of Clinical Pharmacology|January 1, 1987
A modified pharmacokinetic model for platinum disposition in ovarian cancer patients receiving cisplatinH Griffiths, M D Shelley, R G Fish
The Cochrane Database of Systematic Reviews|March 1, 2002
Surgery versus radiotherapy for muscle invasive bladder cancerM D Shelley, J Barber, T Wilt, et al.
Anti-Cancer Drugs|June 1, 2000
Structure-activity studies on gossypol in tumor cell linesM D Shelley, L Hartley, P W Groundwater, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 12, 2004
A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?M D Shelley, T J Wilt, J Barber, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapyR G Fish, M D Shelley, T Maughan, et al.
Pageof 3